Coronary Disease
746
32
52
552
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
53 trials with published results (7%)
Research Maturity
552 completed trials (74% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.2%
24 terminated out of 746 trials
95.8%
+9.3% vs benchmark
20%
148 trials in Phase 3/4
10%
53 of 552 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 552 completed trials
Clinical Trials (746)
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System
Evaluating New Radiation Techniques for Cardiovascular Imaging
Soy Food and Coronary Heart Disease in Women
Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave
Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.
The International Survey of Acute Coronary Syndromes-ARCHIVES
Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Multivessel TALENT
Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)
ANGiographic Evaluation of Left Main Coronary Artery INtErvention
Comparison Between Optical Coherence Tomography and Intravascular Ultrasound for Intermediate Left Main Coronary Artery Lesions
Cardiovascular Health Study (CHS)
Coronary Artery Risk Development in Young Adults
ISCHEMIA-EXTEND (Extended Follow-up)
Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial
Mediators of Atherosclerosis in South Asians Living in America
Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)